P2Y Inhibition beyond Thrombosis Effects on Inflammation - Université de Rennes Accéder directement au contenu
Article Dans Une Revue International Journal of Molecular Sciences Année : 2020

P2Y Inhibition beyond Thrombosis Effects on Inflammation

Résumé

The P2Y receptor is a key player in platelet activation and a major target for antithrombotic drugs. The beneficial effects of P2Y receptor antagonists might, however, not be restricted to the primary and secondary prevention of arterial thrombosis. Indeed, it has been established that platelet activation also has an essential role in inflammation. Additionally, nonplatelet P2Y receptors present in immune cells and vascular smooth muscle cells might be effective players in the inflammatory response. This review will investigate the biological and clinical impact of P2Y receptor inhibition beyond its platelet-driven antithrombotic effects, focusing on its anti-inflammatory role. We will discuss the potential molecular and cellular mechanisms of P2Y-mediated inflammation, including cytokine release, platelet-leukocyte interactions and neutrophil extracellular trap formation. Then we will summarize the current evidence on the beneficial effects of P2Y antagonists during various clinical inflammatory diseases, especially during sepsis, acute lung injury, asthma, atherosclerosis, and cancer.
Fichier principal
Vignette du fichier
ijms-21-01391.pdf (1.07 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02498633 , version 1 (04-03-2020)

Licence

Paternité

Identifiants

Citer

Alexandre Mansour, Christilla Bachelot-Loza, Nicolas Nesseler, Pascale Gaussem, Isabelle Gouin-Thibault. P2Y Inhibition beyond Thrombosis Effects on Inflammation. International Journal of Molecular Sciences, 2020, 21 (4), pp.1391. ⟨10.3390/ijms21041391⟩. ⟨hal-02498633⟩
35 Consultations
68 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More